Advisor Partners LLC lifted its stake in shares of AmerisourceBergen Corp. (NYSE:ABC) by 4.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,298 shares of the company’s stock after purchasing an additional 180 shares during the quarter. Advisor Partners LLC’s holdings in AmerisourceBergen were worth $393,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. BlackRock Inc. grew its stake in shares of AmerisourceBergen by 1.1% during the 2nd quarter. BlackRock Inc. now owns 12,325,863 shares of the company’s stock worth $1,050,903,000 after purchasing an additional 136,458 shares during the period. Boston Partners grew its stake in shares of AmerisourceBergen by 2.0% during the 3rd quarter. Boston Partners now owns 2,449,406 shares of the company’s stock worth $201,708,000 after purchasing an additional 46,948 shares during the period. Parametric Portfolio Associates LLC grew its stake in shares of AmerisourceBergen by 1.5% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 940,152 shares of the company’s stock worth $77,403,000 after purchasing an additional 13,858 shares during the period. Nuveen Asset Management LLC grew its stake in shares of AmerisourceBergen by 111.5% during the 2nd quarter. Nuveen Asset Management LLC now owns 738,360 shares of the company’s stock worth $62,953,000 after purchasing an additional 389,252 shares during the period. Finally, SPF Beheer BV grew its stake in shares of AmerisourceBergen by 3.4% during the 4th quarter. SPF Beheer BV now owns 734,405 shares of the company’s stock worth $62,439,000 after purchasing an additional 24,023 shares during the period. 66.71% of the stock is currently owned by institutional investors and hedge funds.
ABC has been the topic of a number of recent analyst reports. Argus reaffirmed a “buy” rating and set a $110.00 price target on shares of AmerisourceBergen in a research note on Monday, November 18th. TheStreet raised shares of AmerisourceBergen from a “c+” rating to a “b-” rating in a research note on Friday, December 6th. ValuEngine cut shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Friday, November 1st. Finally, Barclays reaffirmed a “hold” rating and set a $100.00 price target on shares of AmerisourceBergen in a research note on Sunday, January 19th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the stock. AmerisourceBergen currently has an average rating of “Hold” and a consensus price target of $91.50.
Shares of NYSE ABC opened at $87.52 on Tuesday. The stock has a market cap of $18.31 billion, a price-to-earnings ratio of 21.72, a PEG ratio of 1.59 and a beta of 0.96. AmerisourceBergen Corp. has a 52 week low of $70.55 and a 52 week high of $94.75. The company’s 50-day moving average price is $86.70 and its 200 day moving average price is $86.16. The company has a current ratio of 0.95, a quick ratio of 0.58 and a debt-to-equity ratio of 1.45.
AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.61 EPS for the quarter, beating the Zacks’ consensus estimate of $1.58 by $0.03. The firm had revenue of $45.64 billion for the quarter, compared to analysts’ expectations of $45.15 billion. AmerisourceBergen had a net margin of 0.48% and a return on equity of 48.84%. The firm’s revenue was up 5.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.45 EPS. As a group, research analysts expect that AmerisourceBergen Corp. will post 7.53 earnings per share for the current year.
In related news, CEO Steven H. Collis sold 19,905 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $86.08, for a total value of $1,713,422.40. Following the sale, the chief executive officer now directly owns 154,484 shares of the company’s stock, valued at approximately $13,297,982.72. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Gina Clark sold 10,917 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $88.24, for a total transaction of $963,316.08. Over the last three months, insiders sold 64,724 shares of company stock worth $5,561,840. 27.80% of the stock is owned by corporate insiders.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Read More: How do candlesticks reflect price movement?
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.